Galderma Laboratories LP v. Revance Therapeutics, Inc.

Good Law
United States District Court, Central District of CaliforniaSeptember 19, 20242:23-cv-02879California369 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA 10 GALDERMA LABORATORIES LP, Case No. 2:23-cv-02879-FLA (SKx)

Plaintiff,

ORDER TO SHOW CAUSE WHY

v. ACTION SHOULD NOT BE

CONSOLIDATED WITH

GALDERMA LABORATORIES LP V.

REVANCE THERAPEUTICS, INC.,

CHAD TISCKOS, CASE NO. 2:21-CV- Defendant. 05522

17 18 19 20 21 22 23 24 25 26 27 28 ORDER TO SHOW CAUSE Pursuant to Fed. R. Civ. P. 42(a), a court may consolidate actions involving “a common question of law or fact” and has “broad discretion under this rule to consolidate cases pending in the same district.” Jnvs. Rsch. Co. v. U.S. Dist. Ct. for Cent. Dist. of California, 877 F.2d 777, 777 (9th Cir. 1989); see also In re Adams Apple, Inc., 829 F.2d 1484, 1487 (9th Cir. 1987) (courts “may consolidate cases sua sponte’) (citation omitted). “To determine whether to consolidate, a court weighs the 8 interest in judicial convenience against the potential for delay, confusion,…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.